HURA Latest Press Releases

-- December 15, 2025 --

TuHURA Biosciences Announces its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone PRNewswire 7:50 AM

-- December 11, 2025 --

TuHURA Biosciences Provides Corporate Update Following Recent Financing PRNewswire 7:30 AM

-- December 9, 2025 --

TuHURA Biosciences, Inc. Announces $15.6 Million Registered Direct Offering PRNewswire 9:50 AM

-- December 8, 2025 --

TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to Immune Checkpoint Inhibitors at the 57th ASH Annual Meeting and Exposition PRNewswire 7:50 AM

-- November 14, 2025 --

TuHURA Biosciences, Inc. Reports Third Quarter 2025 Financial Results and Provides a Corporate Update PRNewswire 7:00 AM

-- November 3, 2025 --

TuHURA Biosciences Discovery Research on Targeting the Delta Opioid Receptor (DOR) to Reprogram Myeloid-Derived Suppressor Cells (MDSCs) Selected for Oral Presentation at the 67th ASH Annual Meeting and Exposition PRNewswire 9:01 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software